Patent ID: 11919953
Assignee: AMGEN INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 28:
29. The composition of claim 14, wherein the CD112R antigen binding protein comprises (i) a HC amino acid sequence of SEQ ID NO: 29 and a LC amino acid sequence of SEQ ID NO: 30, (ii) a HC amino acid sequence of SEQ ID NO: 59 and a LC amino acid sequence of SEQ ID NO: 60, or (iii) a HC amino acid sequence of SEQ ID NO: 79 and a LC amino acid sequence of SEQ ID NO: 80 and/or the TIGIT antigen binding protein comprises a HC amino acid sequence of SEQ ID NO: 199 and a LC amino acid sequence of SEQ ID NO: 200 or a HC amino acid sequence of SEQ ID NO: 219 and a LC amino acid sequence of SEQ ID NO: 220.